Helicobacter pylori infection is associated with worse severity of Parkinson's disease

Parkinsonism & Related Disorders - Tập 21 - Trang 221-225 - 2015
Ai Huey Tan1, Sanjiv Mahadeva2, Connie Marras3, Abdul Malik Thalha2, Chiun Khang Kiew1, Chia Ming Yeat1, Sheang Wen Ng1, Sheau Phing Ang1, Siew Kian Chow1, Mun Fai Loke4, Jamunarani S. Vadivelu4, Norlinah Ibrahim5, Hoi Sen Yong6, Chong Tin Tan1, Susan H. Fox3, Anthony E. Lang3, Shen-Yang Lim1
1Division of Neurology and the Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, University of Malaya, Kuala Lumpur, Malaysia
2Department of Medicine (Division of Gastroenterology), University of Malaya, Kuala Lumpur, Malaysia
3Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Canada
4Department of Medical Microbiology, University of Malaya, Kuala Lumpur, Malaysia
5Department of Medicine (Division of Neurology), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
6Institute of Biological Sciences, University of Malaya, Kuala Lumpur, Malaysia

Tài liệu tham khảo

Pfeiffer, 2009, Neuroinflammation and Parkinson's disease: the silent battleground, Neurology, 73, 1434, 10.1212/WNL.0b013e3181c2f07d Derkinderen, 2014, Gut feelings about smoking and coffee in Parkinson's disease, Mov Disord, 29, 976, 10.1002/mds.25882 Cersosimo, 2008, Neural control of the gastrointestinal tract: implications for parkinson disease, Mov Disord, 23, 1065, 10.1002/mds.22051 Fasano, 2013, The role of small intestinal bacterial overgrowth in Parkinson's disease, Mov Disord, 28, 1241, 10.1002/mds.25522 Tan, 2014, Small intestinal bacterial overgrowth in Parkinson's disease, Parkinsonism Relat Disord, 20, 535, 10.1016/j.parkreldis.2014.02.019 Lim, 2009, Overview of the extra-nigral aspects of Parkinson disease, Arch Neurol, 66, 167, 10.1001/archneurol.2008.561 Perry, 2003, The impact of systemic infection on the progression of neurodegenerative disease, Nat Rev Neurosci, 4, 103, 10.1038/nrn1032 Pott Godoy, 2008, Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease, Brain, 131, 1880, 10.1093/brain/awn101 Deretzi, 2011, Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases, Curr Mol Med, 11, 696, 10.2174/156652411797536660 Doorn, 2012, Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease, Prog Neurobiol, 98, 222, 10.1016/j.pneurobio.2012.06.005 Strang, 1965, The association of gastro-duodenal ulceration and Parkinson's disease, Med J Aust, 1, 842, 10.5694/j.1326-5377.1965.tb72277.x Nielsen, 2012, Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark, Eur J Neurol, 19, 864, 10.1111/j.1468-1331.2011.03643.x Charlett, 1999, Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome, Acta Neurol Scand, 99, 26, 10.1111/j.1600-0404.1999.tb00654.x Suerbaum, 2002, Helicobacter pylori infection, N Engl J Med, 347, 1175, 10.1056/NEJMra020542 McColl, 2010, Helicobacter pylori infection, New Engl J Med, 362, 1597, 10.1056/NEJMcp1001110 Tan, 2012, Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review, J Dig Dis, 13, 342 Bjarnason, 2005, Helicobacter, 10, 276, 10.1111/j.1523-5378.2005.00330.x Pierantozzi, 2006, Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations, Neurology, 66, 1824, 10.1212/01.wnl.0000221672.01272.ba Lee, 2008, Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease, Mov Disord, 23, 1696, 10.1002/mds.22190 Borgohain, 2008, Helicobacter pylori eradication improves treatment response in advanced Parkinson's disease with motor fluctuations, Mov Disord, 23, S312 Dobbs, 2010, Differential effect of Helicobacter pylori eradication on time trends in brady/hypokinesia and rigidity in idiopathic parkinsonism, Helicobacter, 15, 279, 10.1111/j.1523-5378.2010.00768.x Hasriza, 2013, An open label, single arm study on the effects of H. pylori eradication in Parkinson's disease Tsuboi, 2008, Prevalence of Helicobacter pylori infection among patients with Parkinson's disease: impact on clinical manifestations, Mov Disord, 23, S291 Rees, 2011, Helicobacter pylori eradication for Parkinson's disease, Cochrane Database Syst Rev, 11, 10.1002/14651858.CD008453.pub2 Gabrielli, 2011, Prevalence of small intestinal bacterial overgrowth in Parkinson's disease, Mov Disord, 26, 889, 10.1002/mds.23566 Dukowicz, 2007, Small intestinal bacterial overgrowth: a comprehensive review, Gastroenterol Hepatol, 3, 112 Mahadeva, 2011, Validation study of the leeds dyspepsia questionnaire in a multi-ethnic Asian population, J Gastroenterol Hepatol, 26, 1669, 10.1111/j.1440-1746.2011.06806.x Rushdan, 2005, Validation of C13-urea breath test in a teaching hospital, Med J Malaysia, 60, 27 Goh, 2001, The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country, Eur J Gastroenterol Hepatol, 13, 177, 10.1097/00042737-200102000-00014 Rahne, 2013, Motor fluctuations and Helicobacter pylori in Parkinson's disease, J Neurol, 260, 2974 Supajatura, 2002, Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines, J Immunol, 168, 2603, 10.4049/jimmunol.168.6.2603 Blaser, 1995, Age at establishment of Helicobacter pylori infections and gastric carcinoma, gastric ulcer and duodenal ulcer risk, Cancer Res, 55, 562 Mahadeva, 2005, Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia, Aliment Pharmacol Ther, 21, 1483, 10.1111/j.1365-2036.2005.02455.x